Skip to article frontmatterSkip to article content
Site not loading correctly?

This may be due to an incorrect BASE_URL configuration. See the MyST Documentation for reference.

Exploratory Data Analysis: Summary Report

Purpose

This report summarizes the exploratory data analysis of gender gaps in Healthy Life Expectancy (HALE) and Life Expectancy, along with the predictors used in the Bayesian panel data model. The analysis focuses on OECD countries using the most recent available data up to 2019 (excluding 2020+ to avoid COVID-19 pandemic distortions).

Target Variables

Healthy Life Expectancy (HALE)

HALE at birth measures the average number of years that a person can expect to live in “full health” by taking into account years lived in less than full health due to disease and/or injury. This is the primary target variable for the analysis.

The gender gap is calculated as Female HALE - Male HALE (positive values indicate women live longer in full health).

HALE: Female vs Male and Gap vs Overall (OECD Countries)

Figure 1:HALE: Female vs Male and Gap vs Overall (OECD Countries)

Life Expectancy

Life Expectancy at birth measures the average number of years that a person can expect to live, regardless of health status. This is the secondary target variable, allowing comparison of which factors explain the gender gap in overall life expectancy versus healthy life expectancy.

The gender gap is calculated as Female Life Expectancy - Male Life Expectancy (positive values indicate women live longer).

Life Expectancy: Female vs Male and Gap vs Overall (OECD Countries)

Figure 2:Life Expectancy: Female vs Male and Gap vs Overall (OECD Countries)

Predictors

The following predictors are used in the Bayesian panel data model. All indicators are from IHME (Institute for Health Metrics and Evaluation) Global Burden of Disease data, providing consistent methodology and temporal coverage (1990-2023).

Alcohol Use Disorders

Alcohol use disorders death rates (per 100,000 population) - Deaths from alcohol use disorders. Men typically have higher rates of alcohol-related mortality than women.

Alcohol Use Disorders: Female vs Male and Gap vs Overall (OECD Countries)

Figure 3:Alcohol Use Disorders: Female vs Male and Gap vs Overall (OECD Countries)

Self-Harm (Suicide)

Self-harm (suicide) death rates (per 100,000 population) - Deaths from self-harm (suicide). Men typically have much higher suicide rates than women in most countries.

Self-Harm (Suicide): Female vs Male and Gap vs Overall (OECD Countries)

Figure 4:Self-Harm (Suicide): Female vs Male and Gap vs Overall (OECD Countries)

Interpersonal Violence (Homicide)

Interpersonal violence (homicide) death rates (per 100,000 population) - Deaths from interpersonal violence (homicide). Men typically have much higher homicide rates than women in most countries.

Interpersonal Violence (Homicide): Female vs Male and Gap vs Overall (OECD Countries)

Figure 5:Interpersonal Violence (Homicide): Female vs Male and Gap vs Overall (OECD Countries)

Road Injuries

Road injuries (road traffic crash) death rates (per 100,000 population) - Deaths from road injuries (road traffic crashes). Men typically have 2-4 times higher road traffic death rates than women due to higher exposure to driving and occupational hazards.

Road Injuries: Female vs Male and Gap vs Overall (OECD Countries)

Figure 6:Road Injuries: Female vs Male and Gap vs Overall (OECD Countries)

Cardiovascular Disease

Cardiovascular diseases death rates (per 100,000 population) - Deaths from cardiovascular diseases. Men typically have higher rates of cardiovascular disease and heart attacks.

Cardiovascular Disease: Female vs Male and Gap vs Overall (OECD Countries)

Figure 7:Cardiovascular Disease: Female vs Male and Gap vs Overall (OECD Countries)

Diabetes

Diabetes mellitus type 2 death rates (per 100,000 population) - Deaths from diabetes mellitus type 2. Diabetes is a chronic condition that can contribute to the gender gap in mortality.

Diabetes: Female vs Male and Gap vs Overall (OECD Countries)

Figure 8:Diabetes: Female vs Male and Gap vs Overall (OECD Countries)

Neoplasms (Cancer)

Neoplasms (cancer) death rates (per 100,000 population) - Deaths from neoplasms (cancer). Different types of cancer have different gender patterns (e.g., lung cancer is often higher in men, breast cancer is female-specific).

Neoplasms (Cancer): Female vs Male and Gap vs Overall (OECD Countries)

Figure 9:Neoplasms (Cancer): Female vs Male and Gap vs Overall (OECD Countries)

Chronic Respiratory Disease

Chronic respiratory diseases death rates (per 100,000 population) - Deaths from chronic respiratory diseases (including COPD, asthma, and other chronic lung conditions). These diseases often have gender differences due to factors such as smoking patterns and occupational exposures.

Chronic Respiratory Disease: Female vs Male and Gap vs Overall (OECD Countries)

Figure 10:Chronic Respiratory Disease: Female vs Male and Gap vs Overall (OECD Countries)

Liver Disease

Liver disease death rates (per 100,000 population) - Deaths from cirrhosis and other chronic liver diseases. Men typically have higher rates of liver disease mortality than women, often due to higher alcohol consumption and hepatitis infections.

Liver Disease: Female vs Male and Gap vs Overall (OECD Countries)

Figure 11:Liver Disease: Female vs Male and Gap vs Overall (OECD Countries)

Unintentional Injuries

Unintentional injuries death rates (per 100,000 population) - Deaths from unintentional injuries (including falls, drowning, fires, and other accidents). These injuries often show gender differences due to occupational exposures and risk-taking behaviors.

Unintentional Injuries: Female vs Male and Gap vs Overall (OECD Countries)

Figure 12:Unintentional Injuries: Female vs Male and Gap vs Overall (OECD Countries)

Summary Statistics

Target Variables by Country

The following tables show HALE and Life Expectancy gender gaps for all OECD countries, ranked by gap size.

CountryHALE_Years_MaleHALE_Years_FemaleHALE_gap
Lithuania63.169.26.06
Latvia6368.75.69
Poland65.1704.93
Estonia65.870.64.79
Slovakia65.569.43.93
Hungary64.768.43.72
South Korea70.674.23.56
Mexico63.9673.1
Czechia66.9703.09
Japan72.1752.93
Slovenia68.871.72.91
Colombia66.469.32.89
Portugal68.871.22.39
Costa Rica68.170.32.26
Finland6971.32.24
France69.871.61.82
United States65.166.91.8
Spain70.972.41.52
Chile68.670.11.41
Austria69.771.11.36
Greece69.170.51.33
Canada69.770.91.25
Türkiye66.667.81.17
Australia69.770.81.16
Italy70.971.91.07
Belgium69.670.60.941
Luxembourg7171.90.915
Denmark69.970.80.895
Germany6969.90.862
United Kingdom69.470.10.695
Israel71.271.80.611
New Zealand69.5700.487
Ireland70.370.70.454
Switzerland71.371.70.338
Norway7171.30.239
Iceland71.371.50.16
Sweden71.371.50.134
Netherlands71.171.10.0186

Summary:

CountryLifeExpectancy_Years_MaleLifeExpectancy_Years_FemaleLifeExpectancy_gap
Lithuania71.580.89.36
Latvia71.1808.92
Estonia74.782.67.92
Poland73.981.57.55
Slovakia74.280.96.67
Hungary7379.56.54
Mexico72.878.96.09
South Korea80.686.66.01
Portugal78.484.15.77
Czechia76.381.95.63
Slovenia78.6845.47
Japan81.787.25.45
France79.885.25.38
Colombia75.380.55.22
Spain80.585.75.12
Finland79.184.25.04
Türkiye75.180.15.04
Costa Rica77.982.74.78
Chile78.783.34.68
United States76.5814.45
Germany78.783.24.44
Austria79.483.84.33
Greece78.8834.21
Belgium79.583.74.15
Italy80.984.93.98
Luxembourg80.884.73.92
Australia80.784.63.85
Canada80.183.93.77
Israel80.784.33.58
Denmark79.583.13.57
United Kingdom79.582.93.42
Switzerland81.885.13.36
Ireland80.383.63.33
New Zealand80.283.43.27
Sweden81.284.23.07
Norway81.184.23.04
Netherlands80.883.82.91
Iceland81.183.92.8

Summary:

Predictors: Rates and Gaps

The following tables summarize the distribution of predictors across OECD countries, showing both overall rates (midpoint between male and female values) and gender gaps.

IndicatorMedian RateMin RateMax RateCorr HALECorr LE
Neoplasms26580.33650.2140.228
Cardiovascular2411137460.6890.721
ChronicRespiratory43.717.185.4-0.537-0.517
UnintentionalInjury26.510.746.40.220.259
Diabetes18.57.4610.3380.377
LiverDisease15.53.0936.50.7340.74
Suicide134.229.50.5380.511
RoadTraffic5.682.4616.20.4450.418
Alcohol3.090.193150.5590.545
DrugDisorder2.140.21220.8-0.194-0.232
Homicide1.130.45730.50.2560.213
COVID000

Summary:

IndicatorMedian GapMin GapMax GapCorr HALECorr LE
Neoplasms57.6-0.7881320.4540.519
Suicide13.84.5140.20.7480.733
LiverDisease9.651.2932.60.7240.733
ChronicRespiratory8.03-19.334.10.4750.55
RoadTraffic5.62.04220.420.402
UnintentionalInjury4.95-11.237.10.8330.848
Alcohol3.570.30623.60.6180.602
DrugDisorder1.660.022616-0.0636-0.0932
Homicide0.887-0.062247.50.2330.19
COVID000
Diabetes-0.173-9.835.5-0.478-0.564
Cardiovascular-19-12425.6-0.596-0.633

Summary:

Target Variables: Rates and Gaps

IndicatorMedianMinMax
HALE70.165.573.5
Life Expectancy81.475.584.4

Summary:

IndicatorMedian GapMin GapMax Gap
HALE1.390.01866.06
Life Expectancy4.562.89.36

Summary:

Relationships Between Predictors

Rate-Gap Correlations

The following table shows correlations between overall rates (Mid) and gender gaps (Gap) for each predictor.

IndicatorCorrelation
Homicide0.999
Alcohol0.982
RoadTraffic0.971
DrugDisorder0.957
LiverDisease0.955
Suicide0.9
Neoplasms0.685
UnintentionalInjury0.0346
ChronicRespiratory-0.0787
Diabetes-0.325
Cardiovascular-0.804
COVID

Summary:

Inter-Predictor Correlations

The following tables show correlations between predictors, helping identify which predictors tend to co-occur or are related.

Rate 1Rate 2Correlation
UnintentionalInjuryNeoplasms0.721
RoadTrafficHomicide0.687
CardiovascularNeoplasms0.633
CardiovascularLiverDisease0.631
AlcoholCardiovascular0.61
HomicideNeoplasms-0.601
UnintentionalInjurySuicide0.591
AlcoholUnintentionalInjury0.543
UnintentionalInjuryCardiovascular0.536
AlcoholSuicide0.534

Summary:

Gap 1Gap 2Correlation
ChronicRespiratoryNeoplasms0.734
RoadTrafficHomicide0.723
AlcoholCardiovascular-0.688
AlcoholSuicide0.675
UnintentionalInjurySuicide0.633
CardiovascularSuicide-0.613
UnintentionalInjuryLiverDisease0.577
CardiovascularNeoplasms-0.564
ChronicRespiratoryDiabetes-0.564
AlcoholLiverDisease0.542

Summary:

Key Findings

Gender Gaps in Target Variables

  1. HALE Gap: Women consistently live longer in full health than men across OECD countries, with gaps ranging from approximately 1 to 6 years.

  2. Life Expectancy Gap: Women consistently live longer overall than men, with gaps typically larger than HALE gaps (ranging from approximately 2 to 8 years).

  3. Relationship: The correlation between HALE gap and Life Expectancy gap is strong, indicating that countries with larger gender differences in total life expectancy also tend to have larger gender differences in healthy life expectancy.

Gender Gaps in Predictors

  1. External Causes: Gender gaps are largest for external causes of death (road traffic, homicide, suicide), with men having substantially higher rates than women.

  2. Chronic Diseases: Gender gaps in chronic diseases (cardiovascular, neoplasms, chronic respiratory) vary by disease type and country, with some showing larger gaps than others.

  3. Substance-Related: Gender gaps in alcohol use disorders and liver disease are substantial, with men having higher rates, consistent with higher alcohol consumption patterns.

Relationships Between Predictors and Outcomes

  1. Strong Correlations: Predictor gaps with strong correlations to HALE and Life Expectancy gaps are likely important drivers of gender differences in these outcomes.

  2. Rate vs Gap: The relationship between overall rates and gender gaps varies by indicator, with some showing strong correlations and others showing independence.

  3. Co-occurrence: High correlations between predictors suggest shared underlying factors (e.g., socioeconomic conditions, healthcare access, cultural norms) that affect multiple mortality causes simultaneously.

Data Quality and Coverage

Next Steps

This exploratory analysis provides the foundation for:

  1. Bayesian Panel Data Modeling: Using both temporal and cross-country variation to identify predictors of gender gaps

  2. Counterfactual Analysis: Understanding how changes in predictor values would affect gender gaps

  3. Policy Implications: Identifying which factors are most important for reducing gender gaps in healthy life expectancy